<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8157658</article-id>
    <article-id pub-id-type="publisher-id">4191</article-id>
    <article-id pub-id-type="doi">10.1186/s12859-021-04191-8</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>CpGmotifs: a tool to discover DNA motifs associated to CpG methylation events</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Scala</surname>
          <given-names>Giovanni</given-names>
        </name>
        <address>
          <email>giovanni.scala@unina.it</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Federico</surname>
          <given-names>Antonio</given-names>
        </name>
        <address>
          <email>antonio.federico@tuni.fi</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9195-9003</contrib-id>
        <name>
          <surname>Greco</surname>
          <given-names>Dario</given-names>
        </name>
        <address>
          <email>dario.greco@tuni.fi</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.4691.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 0790 385X</institution-id><institution>Department of Biology, </institution><institution>University of Naples “Federico II”, </institution></institution-wrap>80126 Naples, Italy </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.502801.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2314 6254</institution-id><institution>Faculty of Medicine and Health Technology, </institution><institution>Tampere University, </institution></institution-wrap>33014 Tampere, Finland </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.502801.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2314 6254</institution-id><institution>Finnish Hub for Development and Validation of Integrated Approaches (FHAIVE), Tampere University, </institution></institution-wrap>33014 Tampere, Finland </aff>
      <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.7737.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 0410 2071</institution-id><institution>Institute of Biotechnology, </institution><institution>University of Helsinki, </institution></institution-wrap>00014 Helsinki, Finland </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>26</day>
      <month>5</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>26</day>
      <month>5</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2021</year>
    </pub-date>
    <volume>22</volume>
    <elocation-id>278</elocation-id>
    <history>
      <date date-type="received">
        <day>10</day>
        <month>7</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>12</day>
        <month>5</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">The investigation of molecular alterations associated with the conservation and variation of DNA methylation in eukaryotes is gaining interest in the biomedical research community. Among the different determinants of methylation stability, the DNA composition of the CpG surrounding regions has been shown to have a crucial role in the maintenance and establishment of methylation statuses. This aspect has been previously characterized in a quantitative manner by inspecting the nucleotidic composition in the region. Research in this field still lacks a qualitative perspective, linked to the identification of certain sequences (or DNA motifs) related to particular DNA methylation phenomena.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">Here we present a novel computational strategy based on short DNA motif discovery in order to characterize sequence patterns related to aberrant CpG methylation events. We provide our framework as a user-friendly, shiny-based application, CpGmotifs, to easily retrieve and characterize DNA patterns related to CpG methylation in the human genome. Our tool supports the functional interpretation of deregulated methylation events by predicting transcription factors binding sites (TFBS) encompassing the identified motifs.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">CpGmotifs is an open source software. Its source code is available on GitHub <ext-link ext-link-type="uri" xlink:href="https://github.com/Greco-Lab/CpGmotifs">https://github.com/Greco-Lab/CpGmotifs</ext-link> and a ready-to-use docker image is provided on DockerHub at <ext-link ext-link-type="uri" xlink:href="https://hub.docker.com/r/grecolab/cpgmotifs">https://hub.docker.com/r/grecolab/cpgmotifs</ext-link>.</p>
      </sec>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s12859-021-04191-8.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>DNA methylation</kwd>
      <kwd>DNA motifs</kwd>
      <kwd>DNA methylation signature</kwd>
      <kwd>Transcription factors</kwd>
      <kwd>R-Shiny</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100010767</institution-id>
            <institution>Innovative Medicines Initiative</institution>
          </institution-wrap>
        </funding-source>
        <award-id>821511</award-id>
        <principal-award-recipient>
          <name>
            <surname>Greco</surname>
            <given-names>Dario</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2021</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par11">DNA methylation aberration has been associated with several pathological conditions and, more recently, recognized as an important therapeutic target [<xref ref-type="bibr" rid="CR1">1</xref>]. One of the most interesting aspects related to DNA methylation regards the ability of a CpG site to be more or less susceptible to changes in its methylation status. In fact, the propensity of CpG sites to de novo methylation is notably heterogeneous over the whole genome [<xref ref-type="bibr" rid="CR2">2</xref>]. The reasons for such a discrepancy have been widely investigated. For instance, it has been demonstrated that a quantitative relationship exists between the DNA sequence composition and the stability of the associated methylation patterns [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. While this quantitative relationship has been extensively studied [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>], the existence of qualitative features between a particular DNA sequence and its methylation status has not been fully explored. The concept of DNA motif can be used to associate CpG methylation changes to their DNA context [<xref ref-type="bibr" rid="CR1">1</xref>]. The usage of DNA motifs allows researchers to easily explore families of closely related DNA sequences that are over-represented in a set of sequences of interest. Such an approach has been used in [<xref ref-type="bibr" rid="CR7">7</xref>] to identify DNA motifs that regulate DNA methylation, in [<xref ref-type="bibr" rid="CR8">8</xref>] to identify transcription factor-based epigenetic signatures in neural cells and in [<xref ref-type="bibr" rid="CR1">1</xref>] DNA sequences associated to changes in methylation patterns in different cancer types. The concept of methylation related motifs analysis has already been implemented in several other tools in the literature. For example, SEMplMe [<xref ref-type="bibr" rid="CR9">9</xref>] uses motif analysis to predict the effects of methylation patterns measured in a BS experiment within binding site regions derived from a ChIP-seq experiment. Also, MotifMaker [<xref ref-type="bibr" rid="CR10">10</xref>] identifies motifs associated with SMRT output methylation sequences. Here, we propose a strategy aimed to identify DNA motifs over-represented in a set of aberrantly methylated DNA sequences, obtained from a microarray-based DNA methylation experiment. This allows the user to pinpoint DNA motifs which are prone to undergo aberrant methylation in a certain biological condition. Moreover, our tool predicts transcription factor binding sites (TFBS) encompassing the identified motifs hence facilitating the exploration of possible consequences of specific DNA methylation patterns on the downstream gene transcriptional regulation. In this way, our tool supports the user in the biological interpretation of the results of a DNA methylation experiment. We developed CpGmotifs, an interactive tool based on a Graphical User Interface (GUI) implemented in R-Shiny. CpGmotifs provides a seamless and straightforward analytic flow to researchers investigating DNA motifs associated with methylation changes.</p>
  </sec>
  <sec id="Sec2">
    <title>Implementation</title>
    <sec id="Sec3">
      <title>Input</title>
      <p id="Par12">The input is constituted by one or more foreground sets of CpGs of interest (TargetCpGs) and one background set (BackCpGs). Each TargetCpG set is provided as a tab separated file containing 3 mandatory columns and an optional column. Each TargetCpG set consists of a table where each CpG is annotated with its methylation status (hyper-methylated or hypo-methylated). The background set represents the universe, typically defined as the whole set of tested CpGs, from which the TargetCpG set is derived. A flanking region size around each CpG site is used to retrieve the flanking sequences of each CpG site in the reference genome. The choice of the region size depends on various factors that are related to (1) the particular biological question, (2) the chosen motif search algorithm, and (3) the computational resources. In the next step, the tool retrieves the target and background flanking sequence sets using the BSgenome R package (<ext-link ext-link-type="uri" xlink:href="https://www.bioconductor.org/packages/release/bioc/html/BSgenome.html">https://www.bioconductor.org/packages/release/bioc/html/BSgenome.html</ext-link>).</p>
    </sec>
    <sec id="Sec4">
      <title>Motif discovery</title>
      <p id="Par13">The target and the background sequence sets are then provided as the input to a de novo DNA motif search tool. For this task, we make use of the DREME [<xref ref-type="bibr" rid="CR11">11</xref>] tool from the MEME suite, which provides in output enriched DNA motifs. Once the enrichment analysis is completed, statistically significant motifs, along with corresponding information, are collected. In particular, for each significant motif, the following information is retrieved by parsing the DREME output xml file in R: (1) the motif consensus sequence; (2) the motif enrichment e-value; (3) the number of sequences carrying the motif in the TargetCpGs-seqs set; (4) the number of sequences not carrying the motif in the TargetCpGs-seqs set. For each discovered motif, the tool retrieves the corresponding list of CpGs containing the motif in their flanking sequence. This is accomplished by retrieving from the TargetCpGs sequences set all the motif consensus sequences reported in the DREME output. Once this set is obtained, the tool annotates the discovered motifs with the following additional fields (as reported in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1):<list list-type="bullet"><list-item><p id="Par14">The number of hyper-methylated CpGs in the supporting set;</p></list-item><list-item><p id="Par15">The number of hypo-methylated CpGs in the supporting set;</p></list-item><list-item><p id="Par16">The methylation ratio of the supporting set (number of hyper-methylated CpGs/number of hypomethylated CpGs);</p></list-item><list-item><p id="Par17">The methylation unbalance p-value, computed by using an enrichment test over the contingency matrix built with hyper(hypo)-methylated CpGs in the supporting set and hyper(hypo)-methylated CpGs in the background set.</p></list-item></list></p>
    </sec>
    <sec id="Sec5">
      <title>Motif characterization</title>
      <p id="Par18">Once the annotated motifs are retrieved, it is possible to compare the obtained motifs among different experimental conditions or the different methylation trends, in order to get an insight on the specificity of the phenomenon under consideration. By using the <italic>pairwiseAlignment</italic> function from the Biostrings R package (<ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/Biostrings.html">https://bioconductor.org/packages/release/bioc/html/Biostrings.html</ext-link>), the tool computes the distance between two motifs using their consensus sequence (provided as IUPAC codes) and a nucleotide substitution matrix obtained through the <italic>nucleotideSubstitutionMatrix</italic> function from the Biostrings R package. The obtained similarity scores are normalized in the interval [0–1] using min-max normalization and the corresponding distance is computed as its complement to 1. Once the distance between all pairs of motifs has been obtained, a distance matrix is computed and used to perform clustering analysis. Hierarchical clustering is applied and the results are represented by means of a dendrogram adorned with methylation information from each motif by using the functions provided by the dendextend R package [<xref ref-type="bibr" rid="CR12">12</xref>].</p>
    </sec>
    <sec id="Sec6">
      <title>Regulatory annotation</title>
      <p id="Par19">DNA motifs are primarily used to search for affinities between binding sites of molecules interacting with the DNA, including transcription factors (TFs). In this setting, they can be used to study which TFs show affinity with the discovered motifs, and how their function is modulated by the methylation status of the associated CpG. CpGmotifs interrogates public databases of known motifs such as JASPAR [<xref ref-type="bibr" rid="CR13">13</xref>], using the Tomtom [<xref ref-type="bibr" rid="CR14">14</xref>] tool from the MEME suite and the obtained motifs as input. A list of highly similar motifs along with significance p-value and the corresponding binding proteins is returned and associated with each discovered motif (Fig. <xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Search and analysis of DNA motifs related to CpG methylation events. Each box represents one of the intermediate steps of the proposed analysis. For each arrow, the required parameters are reported on the right side, while the employed tools to carry out the step are shown on the left side</p></caption><graphic xlink:href="12859_2021_4191_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Files loading interface. Input files loading interface of the CpGmotifs tool</p></caption><graphic xlink:href="12859_2021_4191_Fig2_HTML" id="MO2"/></fig></p>
    </sec>
    <sec id="Sec7">
      <title>CpGmotifs tool</title>
      <p id="Par20">The CpGmotifs tool is built as a user-friendly and intuitive interface in order to allow the users to have a smooth experience throughout the entire analysis. A typical CpGmotifs analysis goes through three main steps, performed by using the three tabs located on the left side of the main interface. The first step consists of loading the required files and annotations, as shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref> (1). In particular, the user first selects the proper annotation (2) that is needed to associate genomic coordinates (and associated sequences) to CpG IDs. The user can then choose between the Illumina Infinium Human Methylation 450K (<ext-link ext-link-type="uri" xlink:href="https://support.illumina.com/array/array_kits/infinium_humanmethylation450_beadchip_kit.html">https://support.illumina.com/array/array_kits/infinium_humanmethylation450_beadchip_kit.html</ext-link>) and the Infinium MethylationEPIC (<ext-link ext-link-type="uri" xlink:href="https://www.illumina.com/products/by-type/microarray-kits/infinium-methylation-epic.html">https://www.illumina.com/products/by-type/microarray-kits/infinium-methylation-epic.html</ext-link>) annotations or, alternatively, load a custom hg19 annotation. Next, the user uploads a CpG background file (3) containing all the CpG sites representing the enrichment background, including their genomic location. Similarly, the user provides one or more target CpG files (4) containing the CpGs of interest for the motif enrichment analysis. All of the uploaded files must be in tab separated format. Finally, the user may set the size of the CpG flanking region where the tool will search for enriched motifs (5).</p>
      <p id="Par21">The second step of the analysis consists in the detection of enriched CpG motifs, as shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>. The user can perform the analysis by selecting the “Motif analysis” tab (6), where, before starting the motifs search (7), the user has the possibility to set several parameters in order to filter and annotate the results of the motif analysis. In particular, the “motif p-value threshold” field (8) indicates the p-value of the Fisher’s Exact test for the enrichment of the positive motifs over the background sequences. The “motifs e-value threshold” field (9) indicates the motif <italic>p</italic>-value times the number of candidate motifs tested. The “methylation unbalance threshold” field (10) indicates the percentage of methylated or unmethylated CpG in order to consider a certain motif as methylated, unmethylated or neutral. The “Unbalance Fisher <italic>p</italic>-value threshold” refers to the Fisher’s test <italic>p</italic>-value for the enrichment of methylated/unmethylated CpGs in the set of CpG sites carrying the motif. As a result, the tool provides a table reporting all the enriched motifs, including their sequence, length, methylation trend and all the information regarding the statistical tests. By pressing the “Export Summary” button (12) the user can export the results table in .csv format. Along with the table, the tool produces two graphical representations of the results through a heatmap and a clustering dendrogram showing the motifs sequence similarity and their methylation trends. A clustering example is provided in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1.</p>
      <p id="Par22">The third step of the analysis consists in the identification of putative TFBS overlapping with the significant motifs. Also, in this case the user has the possibility to fine tune the parameters for the statistical analysis and filter the output of the analysis. In detail, the TF <italic>p</italic>-value threshold field (15) indicates the <italic>p</italic>-value threshold of the Tomtom TF enrichment test. The TF e-value threshold (16) indicates the E-value of the Tomtom TF enrichment test. TF q-value threshold (17) indicates the Benjamini &amp; Hochberg corrected <italic>p</italic>-value, while the TF overlap threshold (18) indicates the minimum overlap (in the optimal alignment) of the TFBS with a certain motif to be included in the analysis. The user has the possibility to download the summary table of the obtained results as .csv file (19). Moreover, the user is provided with a heatmap reporting the TFs for which a TFBS has been identified on the columns and the samples on the rows. A transcription factors annotation example is provided in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S2 and Table S2.<fig id="Fig3"><label>Fig. 3</label><caption><p>Motif analysis interface of the CpGmotifs tool. Panel A: Parameters setting bar. Panel B: Table reporting the analysis output. Panel C: Heatmap summarizing the analysis results. Panel D: hierarchical clustering of motifs and methylation status annotation bar</p></caption><graphic xlink:href="12859_2021_4191_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><p>TFBS motif analysis interface of the CpGmotifs tool. Panel A: Parameters setting bar. Panel B: Table reporting the analysis output. Panel C: Heatmap summarizing the analysis results</p></caption><graphic xlink:href="12859_2021_4191_Fig4_HTML" id="MO4"/></fig></p>
    </sec>
  </sec>
  <sec id="Sec8">
    <title>Results and discussion</title>
    <sec id="Sec9">
      <title>Case study</title>
      <p id="Par23">We showcase the functionalities of CpGmotifs on five sets of differentially methylated probes in isolated cells from whole blood in selected susceptibility genes for inflammatory diseases, from the catalog of published genome-wide association studies (<ext-link ext-link-type="uri" xlink:href="http://www.genome.gov/gwastudies/">http://www.genome.gov/gwastudies/</ext-link>) [<xref ref-type="bibr" rid="CR15">15</xref>], and reanalysed in [<xref ref-type="bibr" rid="CR16">16</xref>]. The included diseases were asthma, atopic dermatitis, rheumatoid arthritis, systemic lupus erythematosus, type 1 and type 2 diabetes. Through the analysis of these differentially methylated probes we sought to identify whether overrepresented DNA motifs (or motifs families) exist in the context of the deregulated probes. Moreover, we aim at identifying the overall methylation trend of the identified motifs and to infer the regulatory implications of the methylation unbalance through the TFBS prediction.</p>
      <p id="Par24">In order to perform the analysis, the Infinium Human Methylation 450K annotation was chosen. The input to the CpGmotifs tool were 5 target CpG files in tab delimited format (Additional file <xref rid="MOESM1" ref-type="media">1</xref>) containing the probes of interest for the five above mentioned inflammatory conditions and the CpG background file containing all the probes reported in the selected annotation. The flanking region size was set to 20. The motif analysis was performed with the following parameters:<list list-type="bullet"><list-item><p id="Par25">Motif <italic>p</italic>-value threshold: 0.05;</p></list-item><list-item><p id="Par26">Motif e-value threshold: 0.05;</p></list-item><list-item><p id="Par27">Methylation unbalance threshold: 0.7;</p></list-item><list-item><p id="Par28">Unbalance Fisher <italic>p</italic>-value threshold: 1;</p></list-item></list>We obtained 7 significantly enriched DNA motifs over all the 5 conditions. Of these motifs, 1 was derived from asthma, 1 from rheumatoid arthritis and 1 from systemic lupus erythematosus, while 2 motifs derived from both type 1 and type 2 diabetes. Overall, 4 motifs were characterized as mainly hyper-methylated, 1 motif as hypo-methylated and 2 as neutral. To the best of our knowledge, none of the motifs were previously associated with the relative diseases, meaning that our results could represent an unexplored ground of investigation. The Fig. <xref rid="Fig3" ref-type="fig">3</xref> shows a heatmap based on the sequence similarity of the motifs, while the clustering dendrogram underlines the methylation unbalance trend for each motif.</p>
      <p id="Par29">Subsequently, we the TFBS analysis was performed with the following parameters:<list list-type="bullet"><list-item><p id="Par30">TF <italic>p</italic>-value threshold: 0.05;</p></list-item><list-item><p id="Par31">TF e-value threshold: 10;</p></list-item><list-item><p id="Par32">TF q-value threshold: 1;</p></list-item><list-item><p id="Par33">TF overlap threshold: 1;</p></list-item></list>As a result, a total of eight TFBS were found to be significantly associated with the identified DNA motifs (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). Of these TFs, three were associated with the motif TGAWAAA deriving from the asthma dataset. Three TFs were associated with the motif AAAYGAAA deriving from type 1 diabetes, while 1 TF is associated with rheumatoid arthritis and 1 from systemic lupus erythematosus. The 3 TFs identified in the asthma dataset are EOMES, NFATC2, and NFAT5 and are known to regulate gene expression during immune responses. In the immune system, Eomes can positively influence the expression of IFN<inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\gamma$$\end{document}</tex-math><mml:math id="M2"><mml:mi>γ</mml:mi></mml:math><inline-graphic xlink:href="12859_2021_4191_Article_IEq1.gif"/></alternatives></inline-formula> in CD8+ T-cells [<xref ref-type="bibr" rid="CR17">17</xref>]. NFAT5 regulates the expression of the TNF<inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\alpha$$\end{document}</tex-math><mml:math id="M4"><mml:mi>α</mml:mi></mml:math><inline-graphic xlink:href="12859_2021_4191_Article_IEq2.gif"/></alternatives></inline-formula>, participating in specific aspects of host defense by upregulating genes of the TNF family and other target genes in T cells subjected to osmotic stress [<xref ref-type="bibr" rid="CR18">18</xref>]. On the other hand, NFATc2 is a key transcription factor to the pathogenesis of allergic responses [<xref ref-type="bibr" rid="CR19">19</xref>]. It has been demonstrated that its deficiency leads to increased airway hyperresponsiveness (AHR), both after sensitization and in the absence of exogenous allergen challenge. The 3 TFs identified in type 1 diabetes are IRF1, IRF2, IRF7. Aberrations in IRF signaling cascade can lead to increased expression of type I interferon (IFN) genes, IFN-stimulated genes (ISGs), and other pro-inflammatory cytokines/chemokines, leading to the development of numerous diseases, including ones of autoimmune origin, such as type 1 Diabetes. Transcription factor interferon regulatory factor 1 (IRF1), is a downstream target of IFN-gamma/signal transducer and activator of transcription (STAT)-1 and is actively involved in immune-mediated beta cell destruction. It is typically induced by IFN-<inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\gamma$$\end{document}</tex-math><mml:math id="M6"><mml:mi>γ</mml:mi></mml:math><inline-graphic xlink:href="12859_2021_4191_Article_IEq3.gif"/></alternatives></inline-formula> via binding of STAT-1 to the IFN-<inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\gamma$$\end{document}</tex-math><mml:math id="M8"><mml:mi>γ</mml:mi></mml:math><inline-graphic xlink:href="12859_2021_4191_Article_IEq4.gif"/></alternatives></inline-formula>-activation site in the IRF-1 promoter, but other cytokines and hormones can also trigger its expression. IRF-1 is involved in insulin secretion and, especially, in the modulation of chemokine expression by beta cells [<xref ref-type="bibr" rid="CR20">20</xref>]. IRF2 is a negative regulator of IFN-mediated gene expression. IRF2 suppresses the activity of IRF1 by competing for binding sites. IRF7 has also been implicated in the pathogenesis of type 1 diabetes through the upregulation of inflammatory gene networks [<xref ref-type="bibr" rid="CR21">21</xref>]. Abnormal expression of Fli-1 is important in the etiology of autoimmune diseases such as systemic lupus erythematosus and systemic sclerosis. Fli-1 is expressed in peripheral blood mononucleated cells and its overexpression correlates with severity of disease in lupus patients [<xref ref-type="bibr" rid="CR22">22</xref>].</p>
    </sec>
  </sec>
  <sec id="Sec10">
    <title>Conclusions</title>
    <p id="Par34">Here, we presented a novel bioinformatic procedure along with an intuitive graphical interface software to perform the analysis of the sequence context of regions related to DNA methylation events. The comprehension of the relationship linking DNA methylation alterations and proximal DNA sequences is an important step in understanding of the DNA methylation mechanisms and to better identify therapeutic targets in diseases related to methylation aberrations. The technique presented here can be applied to a wide range of public data sets, since it only requires a list of CpGs along with their methylation status. The current implementation supports CpG lists derived from relatively small (hundreds of thousands) set of tested CpGs from the human genome like data derived from the Illumina Infinium 450k or Epic platforms. However, our tool is also able to process CpG lists derived from Whole Genome or Targeted Bisulphite Sequencing. We focused the analysis on CpG methylation events, being the most studied DNA modification, but the analysis can seamlessly be applied to other cytosine modifications in the CHG and CHH contexts.</p>
  </sec>
  <sec id="Sec11">
    <title>Availability and requirements</title>
    <p id="Par35">Project name: CpGmotifs</p>
    <p id="Par36">Project home page: <ext-link ext-link-type="uri" xlink:href="https://github.com/Greco-Lab/CpGmotifs">https://github.com/Greco-Lab/CpGmotifs</ext-link></p>
    <p id="Par37">Operating system(s): Cross Platform</p>
    <p id="Par38">Programming language: R</p>
    <p id="Par39">Other requirements: Docker</p>
    <p id="Par40">License: GPL</p>
    <p id="Par41">Any restrictions to use by non-academics: For commercial use and modifications please contact the corresponding author.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Information</title>
    <sec id="Sec12">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="12859_2021_4191_MOESM1_ESM.pdf">
            <caption>
              <p><bold>Additional file 1</bold>. Examples of output results obtained by CpGmotifs analysis.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>AHR</term>
        <def>
          <p id="Par4">Airways hyperresponsiveness</p>
        </def>
      </def-item>
      <def-item>
        <term>DREME</term>
        <def>
          <p id="Par5">Discriminative regular expression Motif elicitation</p>
        </def>
      </def-item>
      <def-item>
        <term>GUI</term>
        <def>
          <p id="Par6">Graphical user interface</p>
        </def>
      </def-item>
      <def-item>
        <term>IUPAC</term>
        <def>
          <p id="Par7">International union of pure and applied chemistry</p>
        </def>
      </def-item>
      <def-item>
        <term>TF</term>
        <def>
          <p id="Par8">Transcription factor</p>
        </def>
      </def-item>
      <def-item>
        <term>TFBS</term>
        <def>
          <p id="Par9">Transcription factor binding site</p>
        </def>
      </def-item>
      <def-item>
        <term>MEME</term>
        <def>
          <p id="Par10">Multiple Em for Motif Elicitation</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>The authors are grateful to Troy Faithfull for his critical comments on the manuscript.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>GS, DG: Conceived and designed the software; GS, AF: performed the analysis and interpreted the results; GS, AF: drafted the manuscript; DG: supervised the activities and revised the manuscript. All authors have read and agreed to the published version of the manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This study received funding from EU IMI2 project Biomap (Grant Agreement 821511). The funding body was not involved in the design of the study, collection, analysis, and interpretation of data, or in writing the manuscript.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>All the data used herein are publicly available at <ext-link ext-link-type="uri" xlink:href="http://www.genome.gov/gwastudies">http://www.genome.gov/gwastudies</ext-link>.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar2">
      <title>Ethics approval and consent to participate</title>
      <p id="Par42">The data used herein was previously published [<xref ref-type="bibr" rid="CR15">15</xref>] and made publicly available at <ext-link ext-link-type="uri" xlink:href="http://www.genome.gov/gwastudies">http://www.genome.gov/gwastudies</ext-link>.</p>
    </notes>
    <notes id="FPar3">
      <title>Consent for publication</title>
      <p id="Par43">Not applicable.</p>
    </notes>
    <notes id="FPar4" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par44">The authors declare that they have no competing interest.
</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Scala</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Federico</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Palumbo</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Cocozza</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Greco</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Dna sequence context as a marker of cpg methylation instability in normal and cancer tissues</article-title>
        <source>Sci Rep</source>
        <year>2020</year>
        <pub-id pub-id-type="doi">10.1038/s41598-020-58331-w</pub-id>
        <?supplied-pmid 33173088?>
        <pub-id pub-id-type="pmid">33173088</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Feltus</surname>
            <given-names>FA</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>EK</given-names>
          </name>
          <name>
            <surname>Costello</surname>
            <given-names>JF</given-names>
          </name>
          <name>
            <surname>Plass</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Vertino</surname>
            <given-names>PM</given-names>
          </name>
        </person-group>
        <article-title>Predicting aberrant cpg island methylation</article-title>
        <source>Proc Natl Acad Sci</source>
        <year>2003</year>
        <volume>100</volume>
        <issue>21</issue>
        <fpage>12253</fpage>
        <lpage>12258</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.2037852100</pub-id>
        <?supplied-pmid 14519846?>
        <pub-id pub-id-type="pmid">14519846</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Boyes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bird</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Repression of genes by dna methylation depends on cpg density and promoter strength: evidence for involvement of a methyl-cpg binding protein</article-title>
        <source>EMBO J</source>
        <year>1992</year>
        <volume>11</volume>
        <issue>1</issue>
        <fpage>327</fpage>
        <lpage>333</lpage>
        <pub-id pub-id-type="doi">10.1002/j.1460-2075.1992.tb05055.x</pub-id>
        <?supplied-pmid 1310933?>
        <pub-id pub-id-type="pmid">1310933</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Baubec</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Schbeler</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Genomic patterns and context specific interpretation of dna methylation</article-title>
        <source>Curr Opin Genet Dev</source>
        <year>2014</year>
        <volume>25</volume>
        <fpage>85</fpage>
        <lpage>92</lpage>
        <pub-id pub-id-type="doi">10.1016/j.gde.2013.11.015</pub-id>
        <?supplied-pmid 24614011?>
        <pub-id pub-id-type="pmid">24614011</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bartlett</surname>
            <given-names>TE</given-names>
          </name>
          <name>
            <surname>Zaikin</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Olhede</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>West</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Teschendorff</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Widschwendter</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Corruption of the intra-gene dna methylation architecture is a hallmark of cancer</article-title>
        <source>PLoS ONE</source>
        <year>2013</year>
        <volume>8</volume>
        <issue>7</issue>
        <fpage>68285</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0068285</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hansen</surname>
            <given-names>KD</given-names>
          </name>
          <name>
            <surname>Timp</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Bravo</surname>
            <given-names>HC</given-names>
          </name>
          <name>
            <surname>Sabunciyan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Langmead</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>McDonald</surname>
            <given-names>OG</given-names>
          </name>
          <name>
            <surname>Wen</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Diep</surname>
            <given-names>DEA</given-names>
          </name>
        </person-group>
        <article-title>Increased methylation variation in epigenetic domains across cancer types</article-title>
        <source>Nat Genet</source>
        <year>2011</year>
        <volume>43</volume>
        <issue>8</issue>
        <fpage>768</fpage>
        <lpage>775</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.865</pub-id>
        <?supplied-pmid 21706001?>
        <pub-id pub-id-type="pmid">21706001</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ngo</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Whitaker</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Ai</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>JEA</given-names>
          </name>
        </person-group>
        <article-title>Identification of dna motifs that regulate dna methylation</article-title>
        <source>Nucl Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <issue>13</issue>
        <fpage>6753</fpage>
        <lpage>6768</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkz483</pub-id>
        <?supplied-pmid 31334813?>
        <pub-id pub-id-type="pmid">31334813</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sanosaka</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Imamura</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hamazaki</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Chai</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Igarashi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ideta-Otsuka</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Miura</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Ito</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Fujii</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Ikeo</surname>
            <given-names>KEA</given-names>
          </name>
        </person-group>
        <article-title>Dna methylome analysis identifies transcription factor-based epigenomic signatures of multilineage competence in neural stem/progenitor cells</article-title>
        <source>Cell Rep</source>
        <year>2017</year>
        <volume>20</volume>
        <issue>12</issue>
        <fpage>2992</fpage>
        <lpage>3003</lpage>
        <pub-id pub-id-type="doi">10.1016/j.celrep.2017.08.086</pub-id>
        <?supplied-pmid 28930691?>
        <pub-id pub-id-type="pmid">28930691</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <mixed-citation publication-type="other">Nishizaki, S.S., Boyle, A.P.: Semplme: A tool for integrating dna methylation effects in transcription factor binding affinity predictions. bioRxiv (2021). 10.1101/2020.08.13.250118.</mixed-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>F-X</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Multimotifmaker: a multi-thread tool for identifying dna methylation motifs from pacbio reads</article-title>
        <source>IEEE/ACM Trans Comput Biol Bioinform</source>
        <year>2020</year>
        <volume>17</volume>
        <issue>1</issue>
        <fpage>220</fpage>
        <lpage>225</lpage>
        <pub-id pub-id-type="doi">10.1109/tcbb.2018.2861399</pub-id>
        <?supplied-pmid 30059318?>
        <pub-id pub-id-type="pmid">30059318</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bailey</surname>
            <given-names>TL</given-names>
          </name>
        </person-group>
        <article-title>Dreme: motif discovery in transcription factor chip-seq data</article-title>
        <source>Bioinformatics</source>
        <year>2011</year>
        <volume>27</volume>
        <issue>12</issue>
        <fpage>1653</fpage>
        <lpage>1659</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btr261</pub-id>
        <?supplied-pmid 21543442?>
        <pub-id pub-id-type="pmid">21543442</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Galili</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>dendextend: an r package for visualizing, adjusting and comparing trees of hierarchical clustering</article-title>
        <source>Bioinformatics</source>
        <year>2015</year>
        <volume>31</volume>
        <issue>22</issue>
        <fpage>3718</fpage>
        <lpage>3720</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btv428</pub-id>
        <?supplied-pmid 26209431?>
        <pub-id pub-id-type="pmid">26209431</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Khan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Fornes</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Stigliani</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gheorghe</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Castro-Mondragon</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>vanderLee</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bessy</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chneby</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kulkarni</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>GEA</given-names>
          </name>
        </person-group>
        <article-title>Jaspar 2018: update of the open-access database of transcription factor binding profiles and its web framework</article-title>
        <source>Nucl Acids Res</source>
        <year>2017</year>
        <volume>46</volume>
        <issue>D1</issue>
        <fpage>1284</fpage>
        <lpage>1284</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1188</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gupta</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Stamatoyannopoulos</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Bailey</surname>
            <given-names>TL</given-names>
          </name>
          <name>
            <surname>Noble</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Quantifying similarity between motifs</article-title>
        <source>Genome Biol</source>
        <year>2007</year>
        <volume>8</volume>
        <issue>2</issue>
        <fpage>24</fpage>
        <pub-id pub-id-type="doi">10.1186/gb-2007-8-2-r24</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hindorff</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Sethupathy</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Junkins</surname>
            <given-names>HA</given-names>
          </name>
          <name>
            <surname>Ramos</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Mehta</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Collins</surname>
            <given-names>FS</given-names>
          </name>
          <name>
            <surname>Manolio</surname>
            <given-names>TA</given-names>
          </name>
        </person-group>
        <article-title>Potential etiologic and functional implications of genome-wide association loci for human diseases and traits</article-title>
        <source>Proc Natl Acad Sci</source>
        <year>2009</year>
        <volume>106</volume>
        <issue>23</issue>
        <fpage>9362</fpage>
        <lpage>9367</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.0903103106</pub-id>
        <?supplied-pmid 19474294?>
        <pub-id pub-id-type="pmid">19474294</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Reinius</surname>
            <given-names>LE</given-names>
          </name>
          <name>
            <surname>Acevedo</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Joerink</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pershagen</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Dahln</surname>
            <given-names>S-E</given-names>
          </name>
          <name>
            <surname>Greco</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sderhll</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Scheynius</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kere</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Differential dna methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility</article-title>
        <source>PLoS ONE</source>
        <year>2012</year>
        <volume>7</volume>
        <issue>7</issue>
        <fpage>41361</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0041361</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Knox</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Cosma</surname>
            <given-names>GL</given-names>
          </name>
          <name>
            <surname>Betts</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>McLane</surname>
            <given-names>LM</given-names>
          </name>
        </person-group>
        <article-title>Characterization of t-bet and eomes in peripheral human immune cells</article-title>
        <source>Front Immunol</source>
        <year>2014</year>
        <pub-id pub-id-type="doi">10.3389/fimmu.2014.00217</pub-id>
        <?supplied-pmid 24860576?>
        <pub-id pub-id-type="pmid">24860576</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Neuhofer</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Role of nfat5 in inflammatory disorders associated with osmotic stress</article-title>
        <source>Curr Genom</source>
        <year>2010</year>
        <volume>11</volume>
        <issue>8</issue>
        <fpage>584</fpage>
        <lpage>590</lpage>
        <pub-id pub-id-type="doi">10.2174/138920210793360961</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Karwot</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Maxeiner</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Schmitt</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Scholtes</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Hausding</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lehr</surname>
            <given-names>HA</given-names>
          </name>
          <name>
            <surname>Glimcher</surname>
            <given-names>LH</given-names>
          </name>
          <name>
            <surname>Finotto</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Protective role of nuclear factor of activated t cells 2 in cd8+ long-lived memory t cells in an allergy model</article-title>
        <source>J Allergy Clin Immunol</source>
        <year>2008</year>
        <volume>121</volume>
        <issue>4</issue>
        <fpage>992</fpage>
        <lpage>9996</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jaci.2007.12.1172</pub-id>
        <?supplied-pmid 18329088?>
        <pub-id pub-id-type="pmid">18329088</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gysemans</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Callewaert</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Moore</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Nelson-Holte</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Overbergh</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Eizirik</surname>
            <given-names>DL</given-names>
          </name>
          <name>
            <surname>Mathieu</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Interferon regulatory factor-1 is a key transcription factor in murine beta cells under immune attack</article-title>
        <source>Diabetologia</source>
        <year>2009</year>
        <volume>52</volume>
        <issue>11</issue>
        <fpage>2374</fpage>
        <lpage>2384</lpage>
        <pub-id pub-id-type="doi">10.1007/s00125-009-1514-5</pub-id>
        <?supplied-pmid 19756487?>
        <pub-id pub-id-type="pmid">19756487</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Heinig</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Petretto</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Wallace</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Bottolo</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Rotival</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Sarwar</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Langley</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Bauerfeind</surname>
            <given-names>AEA</given-names>
          </name>
        </person-group>
        <article-title>A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk</article-title>
        <source>Nature</source>
        <year>2010</year>
        <volume>467</volume>
        <issue>7314</issue>
        <fpage>460</fpage>
        <lpage>464</lpage>
        <pub-id pub-id-type="doi">10.1038/nature09386</pub-id>
        <?supplied-pmid 20827270?>
        <pub-id pub-id-type="pmid">20827270</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zacksenhaus</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Ben-David</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>The ets transcription factor fli-1 in development, cancer and disease</article-title>
        <source>Oncogene</source>
        <year>2014</year>
        <volume>34</volume>
        <issue>16</issue>
        <fpage>2022</fpage>
        <lpage>2031</lpage>
        <pub-id pub-id-type="doi">10.1038/onc.2014.162</pub-id>
        <?supplied-pmid 24909161?>
        <pub-id pub-id-type="pmid">24909161</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
